CRISPR Therapeutics AG - Company Profile

Powered by

All the sales intelligence you need on CRISPR Therapeutics AG in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how CRISPR Therapeutics AG fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with CRISPR Therapeutics AG.

Back to companies

CRISPR Therapeutics AG: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

The following section provides information on CRISPR Therapeutics AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into CRISPR Therapeutics AG's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Samarth Kulkarni

Chairman; Chief Executive Officer Executive Board Since: 2023 Age: 47

Mr. Samarth Kulkarni has been the Chairman and Chief Executive Officer of the company since 2023. Prior to this, he served as the President and Chief Business Officer of the company. Previously, he served as a member of the board of directors of various companies, Black Diamond Therapeutics, Inc, Oruka Therapeutics, Inc, Centessa Pharmaceuticals plc, and Repare Therapeutics Inc.

Read Hide full bio of Samarth Kulkarni

Raju Prasad, Ph.D.

Chief Financial Officer Senior Management Since: 2023 Age: 42

Mr. Raju Prasad, Ph.D. has been the Chief Financial Officer of the company since March 2023. Prior to this, he served as a partner at William Blair & Company From March 2014 to 2023. Previously, he served as a research associate of the University of North Carolina at Chapel Hill’s Gillings School of Global Public Health and U.S. Environmental Protection Agency.

Read Hide full bio of Raju Prasad, Ph.D.

Naimish Patel, M.D.

Chief Medical Officer Senior Management Since: 2024 Age: 54

Mr. Naimish Patel, M.D. has been the Chief Medical Officer of the company since May 2024. Prior to this, he served as Head of Immunology and Inflammation at Sanofi from 2019 to 2024. Previously, he served as Global Program Head for Dupilumab at Sanofi from 2018 to 2019.

Read Hide full bio of Naimish Patel, M.D.

James R. Kasinger

General Counsel; Secretary Senior Management Since: 2017 Age: 54

Megan Wherry Menner

Head - Human Resources Senior Management
Gain a 360-degree view of CRISPR Therapeutics AG and make more informed decisions for your business Gain a 360-degree view of CRISPR Therapeutics AG and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer